Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-Arginine for Severe Vascular Fetal IUGR
NCT00549575Phase 3Terminated
- Sponsor
- CHU de Nantes
- Start
- Jul 2000
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arginine in intrauterine growth restriction (IUGR), sponsored by CHU de Nantes. Started Jul 2000; status: terminated.
02
Drugs
arginine
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on NCT00549575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00549575.